YH02 Injection for Intra-tumor Injection Therapy in Advanced Solid Tumors With Unresponsive or Failure-Treated Cases
NCT07697937
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Advanced Malignant Solid Tumor
Interventions
DRUG:
YH-02
Sponsor
Tianjin First Central Hospital